Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Koelmeyer

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|August 5, 2009
A role for pericytes as microenvironmental regulators of human skin tissue regenerationSophie Paquet-Fifield, Holger Schlüter, Amy Li, et al.
Arthritis Research & Therapy|May 12, 2026
Clinical characteristics and response to standard-of-care treatment in systemic lupus erythematosus patients with or without anti-ribonucleoprotein (RNP) antibodies: an Australian, multi-centre cohort studyRangi Kandane-Rathnayake, Rachel Koelmeyer, Shereen Oon, et al.
BMC Public Health|February 11, 2017
The Australian longitudinal study on male health-methodsDianne Currier, Jane Pirkis, John Carlin, et al.
International Journal of Epidemiology|October 1, 2016
Cohort Profile: Ten to Men (the Australian Longitudinal Study on Male Health)Jane Pirkis, Dianne Currier, John Carlin, et al.
Frontiers in Immunology|September 5, 2018
The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1Jessica C Anania, Halina M Trist, Catherine S Palmer, et al.
Blood|September 5, 2008
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapyTimothy P Hughes, Susan Branford, Deborah L White, et al.
Lupus Science & Medicine|March 18, 2026
Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trialsKathryn Connelly, Eric Morand, Rachel Koelmeyer, et al.
Nature Communications|February 6, 2024
Smith-specific regulatory T cells halt the progression of lupus nephritisPeter J Eggenhuizen, Rachel M Y Cheong, Cecilia Lo, et al.
Nature Reviews. Rheumatology|July 11, 2023
Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforceKathryn Connelly, Laura E Eades, Rachel Koelmeyer, et al.
Rheumatology (Oxford, England)|May 19, 2023
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoringAi Li Yeo, Rangi Kandane-Rathnayake, Rachel Koelmeyer, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|August 5, 2009
A role for pericytes as microenvironmental regulators of human skin tissue regenerationSophie Paquet-Fifield, Holger Schlüter, Amy Li, et al.
Arthritis Research & Therapy|May 12, 2026
Clinical characteristics and response to standard-of-care treatment in systemic lupus erythematosus patients with or without anti-ribonucleoprotein (RNP) antibodies: an Australian, multi-centre cohort studyRangi Kandane-Rathnayake, Rachel Koelmeyer, Shereen Oon, et al.
BMC Public Health|February 11, 2017
The Australian longitudinal study on male health-methodsDianne Currier, Jane Pirkis, John Carlin, et al.
International Journal of Epidemiology|October 1, 2016
Cohort Profile: Ten to Men (the Australian Longitudinal Study on Male Health)Jane Pirkis, Dianne Currier, John Carlin, et al.
Frontiers in Immunology|September 5, 2018
The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1Jessica C Anania, Halina M Trist, Catherine S Palmer, et al.
Blood|September 5, 2008
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapyTimothy P Hughes, Susan Branford, Deborah L White, et al.
Lupus Science & Medicine|March 18, 2026
Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trialsKathryn Connelly, Eric Morand, Rachel Koelmeyer, et al.
Nature Communications|February 6, 2024
Smith-specific regulatory T cells halt the progression of lupus nephritisPeter J Eggenhuizen, Rachel M Y Cheong, Cecilia Lo, et al.
Nature Reviews. Rheumatology|July 11, 2023
Towards a novel clinical outcome assessment for systemic lupus erythematosus: first outcomes of an international taskforceKathryn Connelly, Laura E Eades, Rachel Koelmeyer, et al.
Rheumatology (Oxford, England)|May 19, 2023
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoringAi Li Yeo, Rangi Kandane-Rathnayake, Rachel Koelmeyer, et al.
Pageof 4